###begin article-title 0
###xml 63 68 <span type="species:ncbi:9606">human</span>
ADAM15 gene structure and differential alternative exon use in human tissues
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 102 109 102 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 237 244 237 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 145 150 <span type="species:ncbi:9606">human</span>
###xml 431 436 <span type="species:ncbi:9606">human</span>
ADAM15 is a metalloprotease-disintegrin implicated in ectodomain shedding and cell adhesion. Aberrant ADAM15 expression has been associated with human cancer and other disorders. We have previously shown that the alternative splicing of ADAM15 transcripts is mis-regulated in cancer cells. To gain a better understanding of ADAM15 regulation, its genomic organization and regulatory elements as well as the alternative exon use in human tissues were characterized.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 6 12 6 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15</italic>
###xml 48 58 48 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ephrin-A4 </italic>
###xml 181 186 181 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM </italic>
###xml 751 758 751 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 678 683 <span type="species:ncbi:9606">human</span>
Human ADAM15, flanked by the FLJ32785/DCST1 and ephrin-A4 genes, spans 11.4 kb from the translation initiation codon to the polyadenylation signal, being the shortest multiple-exon ADAM gene. The gene contains 23 exons varying from 63 to 316 bp and 22 introns from 79 to 1283 bp. The gene appeared to have several transcription start sites and their location suggested the promoter location within a CpG island proximal to the translation start. Reporter expression experiments confirmed the location of functional GC-rich, TATAless and CAATless promoter, with the most critical transcription-supporting elements located -266 to -23 bp relative to the translation start. Normal human tissues showed different complex patterns of at least 13 different ADAM15 splice variants arising from the alternative use of the cytosolic-encoding exons 19, 20a/b, and 21a/b. The deduced ADAM15 protein isoforms have different combinations of cytosolic regulatory protein interaction motifs.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 350 357 350 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 371 376 <span type="species:ncbi:9606">human</span>
Characterization of human ADAM15 gene and identification of elements involved in the regulation of transcription and alternative splicing provide important clues for elucidation of physiological and pathological roles of ADAM15. The present results also show that the alternative exon use is a physiological post-transcriptional mechanism regulating ADAM15 expression in human tissues.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM </italic>
###xml 49 50 49 50 <underline xmlns:xlink="http://www.w3.org/1999/xlink">a</underline>
###xml 50 51 50 51 <underline xmlns:xlink="http://www.w3.org/1999/xlink">d</underline>
###xml 62 63 62 63 <underline xmlns:xlink="http://www.w3.org/1999/xlink">a</underline>
###xml 66 67 66 67 <underline xmlns:xlink="http://www.w3.org/1999/xlink">m</underline>
###xml 150 151 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 729 730 729 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 650 655 <span type="species:ncbi:9606">Human</span>
ADAM15 is a widely expressed member of the ADAM (adisintegrin and metalloprotease) gene family encoding transmembrane metalloproteinase-disintegrins [1]. The characteristic domain structure of ADAM proteins consists of N-terminal signal sequence and prodomain, which typically are proteolytically excised during biosynthetic maturation, followed by metalloproteinase, disintegrin, and cysteine-rich domains, a transmembrane segment, and a cytosolic tail. Despite the presence of the conserved metalloproteinase domain, not all ADAMs are active proteinases; roughly half of the over 30 ADAM members do not contain all catalytically critical residues. Human ADAM15 is an active metalloproteinase and can bind to several integrins [2].
###end p 9
###begin p 10
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 360 367 360 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 456 457 456 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 458 459 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 546 552 546 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">adam15</italic>
###xml 552 556 552 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 623 624 623 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 707 708 707 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 709 711 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
###xml 556 560 <span type="species:ncbi:10090">mice</span>
ADAMs have been implicated in numerous physiological and pathological processes through their proteolytic or adhesive activities, including ectodomain shedding and cell-cell interactions [2-5]. ADAM15 has been implicated in activation of growth factors through ectodomain shedding and in cell-cell interactions, but specific physiological roles are not known. ADAM15 gene knockout in mice did not result in obvious developmental or pathological phenotype [6,7]. However, strongly decreased angiogenesis in the retinopathy of prematurity model in adam15-/- mice indicated a critical role in pathological neovascularization [6], corroborated by the studies implicating ADAM15 in regulation of vasculogenesis [8-11].
###end p 10
###begin p 11
###xml 8 15 8 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 135 136 135 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 231 232 231 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 289 296 289 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 332 339 332 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 423 430 423 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 498 500 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 559 566 559 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 389 394 <span type="species:ncbi:9606">human</span>
###xml 467 472 <span type="species:ncbi:10090">mouse</span>
###xml 477 482 <span type="species:ncbi:9606">human</span>
Altered ADAM15 expression has been associated with human diseases, including cancers, cardiac disease, atherosclerosis, and arthritis [9,12-18]. In cancers, ADAM15 has been implicated in tumor growth, angiogenesis, and metastasis [6,8,18]. In addition to the transcriptional regulation of ADAM15 expression, alternative splicing of ADAM15 transcripts has been shown to be mis-regulated in human cancer cells [19]. Although ADAM15 splice-variants have been found from mouse and human cell lines [19-22], no information has been available about the alternative ADAM15 splicing in normal tissues.
###end p 11
###begin p 12
###xml 141 148 141 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 135 140 <span type="species:ncbi:9606">human</span>
###xml 214 219 <span type="species:ncbi:9606">human</span>
To gain better understanding of ADAM15 regulation, the present study provides a detailed structural and functional characterization of human ADAM15 gene as well as its expression and alternative exon use in normal human tissues.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 6 13 6 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human ADAM15 gene structure
###end title 14
###begin p 15
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 197 204 197 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 31 36 <span type="species:ncbi:9606">human</span>
PAC-clone 240C8 containing the human ADAM15 gene was previously identified and shown to hybridize with a single chromosomal locus at 1q21.3 [23]. Sequencing verified that 240C8 includes the entire ADAM15 gene (Fig. 1A). The annotated gene sequence was submitted to GenBank [GenBank: ].
###end p 15
###begin p 16
###xml 6 13 6 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 317 324 317 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 785 792 785 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 873 880 873 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 989 996 989 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 1106 1113 1106 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 2214 2221 2214 2221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 2305 2312 2305 2312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 2406 2413 2406 2413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 2606 2613 2606 2613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 3116 3123 3116 3123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 1278 1283 <span type="species:ncbi:9606">human</span>
###xml 1288 1293 <span type="species:ncbi:10090">mouse</span>
###xml 1385 1390 <span type="species:ncbi:10090">mouse</span>
###xml 1395 1400 <span type="species:ncbi:9606">human</span>
###xml 2849 2853 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Human ADAM15 gene structure, phylogenetic footprinting, promoter and transcription start site analysis. The panels (A), (B), (C), and the left part of the panel (D) are in register respective to the nucleotide numbering shown under the panel (C). The symbol key for the panels (A) - (C) is shown at bottom right. (A) ADAM15 exon-intron structure is depicted with black and grey boxes representing the constitutively and alternatively used exons, respectively. Exon numbering is indicated under the boxes. The alternative exon 20a/b and 21a/b 5'- and 3'-ends are indicated with pale grey. The green boxes represent the last two exons (exons 15 and 16) of the upstream gene FLJ32785. The spaces separating the exons are proportional to the intron lengths. The solid lines connecting the ADAM15 exons represent the most frequently observed splice pattern corresponding to the ADAM15 mRNA variant 2. The dashed lines connecting the exons 18-22 represent the alternative splicing producing the ADAM15 variant with the longest open reading frame (variant 6). The dashed line between the FLJ32785 exon 16 and the ADAM15 exon 2 depicts the observed fusion splicing between the two genes. The panel (B) shows the repetitive element locations. Conservation of repetitive elements between human and mouse is indicated by the letter c. (C) The upper part shows the sequence-similarity between the mouse and human genes, indicated by the identity percentage on the vertical axis; the mVista sequence-identity plot is shown with pink shading in the intronic regions and with blue or green shading in the exonic regions. The PiP-maker identity blocks are shown with black horizontal lines. CpG islands are indicated with white and grey boxes (see the symbol key). The lower part of the panel C shows the locations of predicted transcription factor binding sequences with the relative strength of prediction on the vertical axis; the Match-program was used to predict the conventional binding motifs (solid orange squares) and the Consite for phylogenetically conserved binding motifs (open circles); predictions with scores ranging from 0.90 to 1.00 are shown for Match and from 5 to 15 for Consite. The location relative to the ADAM15 translation start ATG is indicated by the nucleotide numbering under the panel. (D) ADAM15 promoter analysis with luciferase-reporter expression. The left side of the panel D shows the ADAM15 upstream regions examined in the luciferase reporter experiments. The light blue shading indicates the conserved regions outside of the repetitive elements. The nucleotide location relative to ADAM15 translation start ATG, in register with the panel (C), is shown under the panel. The right side of the panel (D) shows the relative promoter activity of the reporter constructs in comparison to the pGL2-Basic control plasmid and to the SV40 promoter. The black and grey bars indicate the promoter activity measured in SK-BR-3 and HCC-1954 cells, respectively. (E) The transcription start site analysis using RT-PCR described in the Materials and Methods. The position of the upstream primer relative to ADAM15 translation start ATG in each PCR is indicated under the electrophoresis lanes. The upper gel shows the products of 30 PCR cycles and the lower gel those of 35 PCR-cycles.
###end p 16
###begin p 17
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 49 59 49 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ephrin-A4 </italic>
###xml 166 173 166 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 202 212 202 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ephrin-A4 </italic>
###xml 402 409 402 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
ADAM15 gene is flanked by the FLJ32785/DCST1 and ephrin-A4 (EFNA4) genes. FLJ32785 (NCBI Entrez GeneID 149095) polyadenylation signal is located 477 bp upstream from ADAM15 translation start codon, and ephrin-A4 (GeneID 1945) translation start 1069 bp downstream from ADAM15 polyadenylation signal. In this report, if not mentioned otherwise, the nucleotide numbering is relative to the adenine of the ADAM15 translation start codon.
###end p 17
###begin p 18
###xml 6 13 6 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 190 197 190 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM </italic>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 308 313 <span type="species:ncbi:9606">human</span>
Human ADAM15 gene spans 11367 bp from the translation start to the polyadenylation signal, contains 23 exons varying from 63 to 316 bp, and 22 introns varying from 79 to 1283 bp. (Fig. 1A). ADAM15 is the shortest multiple-exon ADAM gene (comparison data not shown). The exons 19-21 are used alternatively in human tissues (Fig. 1A).
###end p 18
###begin p 19
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 68 69 68 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 82 89 82 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 239 244 <span type="species:ncbi:9606">human</span>
All ADAM15 introns conform the GT-AG splicing rule (Additional file 1). While the ADAM15 introns in general contain good putative branch sites, the branch sites in the introns 3, 6, 10, and 19 scored lower than average branch sites in the human genome. Although the Branch-Site Anlyzer failed to predict the branch site for intron 1, a good consensus sequence was found at appropriate location. The putative branch site sequences are shown in Additional file 1.
###end p 19
###begin p 20
###xml 55 62 55 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 504 505 504 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 621 623 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 40 45 <span type="species:ncbi:10090">mouse</span>
###xml 51 54 <span type="species:ncbi:10116">rat</span>
###xml 93 98 <span type="species:ncbi:9606">human</span>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
###xml 133 136 <span type="species:ncbi:10116">rat</span>
###xml 262 267 <span type="species:ncbi:9606">human</span>
###xml 360 365 <span type="species:ncbi:9606">human</span>
###xml 472 477 <span type="species:ncbi:9606">human</span>
###xml 521 526 <span type="species:ncbi:9606">human</span>
The intron/exon structure of the human, mouse, and rat ADAM15 genes is almost identical. The human exon 2, the mouse exon 6, and the rat exon 20 show an internal 3 bp deletion respective to the others. Another difference is that the 3'-splice site (3'ss) of the human intron 6 is located three nucleotides downstream from that of the rodent genes, causing the human exon 7 to be 3 bp shorter. The ag corresponding to the 3'ss of the rodent intron 6 is also present in the human sequence (Additional file 1) and hence the human intron 6 acceptor contains a tagtag-sequence constituting a candidate NAGNAG tandem acceptor [24] which could enable 3 bp variation at the exon start. Use of the proximal acceptor would lead to an inframe stop codon (TAG) at the exon 7 start. However, transcripts with the exon 7 stop form have not been detected.
###end p 20
###begin p 21
###xml 83 84 83 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 220 221 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 405 406 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
The exons 20 and 21 have alternative 5'- or 3'-ends, respectively (Additional file 1). The exon 20 forms, the shorter referred as 20a and the longer as 20b, are a consequence of a NAGNAG tandem acceptor (Additional file 1). The alternative exon 21 forms share the 5' splice site (5'ss) and the longer referred as 21b has a 3' splice site (3'ss) 142 bp further downstream from that of 21a (Additional file 1).
###end p 21
###begin p 22
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 126 133 126 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 190 197 190 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 251 258 251 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
The ADAM15 gene contains four separate CpG-islands. The longest CpG-island extends from the last FLJ32785 intron to the first ADAM15 intron (Fig. 1C). Two shorter islands are located within ADAM15 intron 1, and the fourth island encompass region from ADAM15 exon 22 past the polyadenylation site (Fig. 1C).
###end p 22
###begin title 23
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human ADAM15 gene contains several transcription start sites and a TATAless promoter
###end title 23
###begin title 24
Evidence for several transcription start sites
###end title 24
###begin p 25
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 485 492 485 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
5'RACE experiments indicated the presence of several 5'-ends upstream of ADAM15 exon 2, differing in length and sequence (data not shown). However, an impractical number of 5'RACE products would have had to be cloned and sequenced for unambiguous results, due to alternative sequence in similar-sized 5'-ends. For the same reason, primer extension from exon 2 would have produced equivocal results. Therefore the PCR approach described in the Methods was used to analyse the 5' end of ADAM15 transcripts.
###end p 25
###begin p 26
###xml 90 97 90 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 177 184 177 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 84 89 <span type="species:ncbi:9606">human</span>
The gradual decrease of product levels in consecutive PCRs of 5'-UTR indicated that human ADAM15 transcription starts at several sites at different levels (Fig. 1E). While most ADAM15 transcriptions started at around 110 bp upstream from the translation start, transcripts starting from up to -159 bp were detected with 30 PCR cycles (Fig. 1E).
###end p 26
###begin p 27
###xml 100 106 100 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15</italic>
###xml 213 220 213 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 402 408 402 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15</italic>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 684 691 684 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 704 705 704 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
The 5'RACE results also indicated fusion transcription, joining the upstream-neighbour FLJ32785 and ADAM15. This was confirmed using the PCR approach. Transcripts were amplified with a common downstream primer at ADAM15 exon 2 and various upstream primers at FLJ32785 exons 15 and 10. This indicated that fusion transcripts start at least within FLJ32785 exon 10, possibly containing FLJ32785 fused to ADAM15. However, the fusion transcripts were detected only after 35 PCR cycles, indicating their scarcity in the studied cells (Fig. 1E). 5'RACE product and GenBank EST sequences indicate that both GTs flanking the FLJ32785 polyadenylation signal were used as donors in splicing to ADAM15 exon 2 (Fig. 2).
###end p 27
###begin p 28
###xml 58 65 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 85 92 85 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 413 419 413 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15</italic>
###xml 976 983 976 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 79 84 <span type="species:ncbi:9606">human</span>
###xml 173 178 <span type="species:ncbi:10090">mouse</span>
###xml 183 186 <span type="species:ncbi:10116">rat</span>
###xml 407 412 <span type="species:ncbi:9606">human</span>
###xml 532 537 <span type="species:ncbi:9606">human</span>
###xml 552 557 <span type="species:ncbi:10090">mouse</span>
###xml 572 575 <span type="species:ncbi:10116">rat</span>
###xml 823 828 <span type="species:ncbi:9606">human</span>
###xml 970 975 <span type="species:ncbi:9606">human</span>
Comparative transcription factor binding site analysis of ADAM15 promoter. The human ADAM15 promoter and the first exon nucleotide sequences were aligned with corresponding mouse and rat sequences (hsA15, mmA15, and rnA15, respectively). The numbering above the sequences indicates position respective to the adenine in the translation start codon. The amino acid translation is shown for the first exon of human ADAM15. The predicted high-score transcription factor recognition motifs are indicated above the sequence (solid line, human; dotted line, mouse; dashed line, rat). The three conserved 22 bp repeated elements, the translation start ATG, and the polyadenylation signal of the upstream gene FLJ32785 are boxed. The boxed GTs indicate the detected splice donor sites in the last FLJ32785 exon used in splicing of human FLJ32785 to ADAM15. The thick line below the aligned sequences indicates the region containing the detected transcription start sites of the human ADAM15 gene.
###end p 28
###begin p 29
###xml 155 162 155 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 267 274 267 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
The upstream primers at the FLJ32785 intron 15 failed to amplify PCR-products, suggesting that the intron 15 is excluded normally from fusion transcripts. ADAM15 transcripts with FLJ32785 intron 15 sequence at 5' end were not detected, indicating that no alternative ADAM15 transcription start sites are present in the FLJ32785 intron 15. Hence, the transcripts encoding ADAM15 protein start at -159 through -110 region. Given this and the location within a CpG island, this region was examined for promoter activity.
###end p 29
###begin title 30
ADAM15 promoter induced expression in luciferase reporter assay
###end title 30
###begin p 31
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 260 264 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Reporter expression analysis confirmed that the candidate promoter region contained a functional promoter. The region -266 through -23 increased the reporter activity to 1.2- and 1.9-fold in SK-BR-3 and HCC-1954 cells, respectively, as compared to the control SV40-promoter (Fig. 1D).
###end p 31
###begin p 32
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 309 310 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
Deletion of the nucleotides -171 to -122 resulted in the reduction of the promoter activity to a third of the original (Fig. 1D). This weakened mutant promoter lacked five of the six Sp1 recognition motifs and the Pax-4 site, containing only an En-1, a HoxA3, and a composite Sp1/MyoD recognition motif (Fig. 2).
###end p 32
###begin p 33
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 238 245 238 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">adam15 </italic>
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 795 802 795 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 927 934 927 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 224 229 <span type="species:ncbi:10090">mouse</span>
###xml 234 237 <span type="species:ncbi:10116">rat</span>
The upstream segment -415 to -267 showed a weak repressive effect, since its addition to the -266 through -23 construct reduced the promoter activity (Fig. 1D). However, the corresponding sequence is largely absent from the mouse and rat adam15 genes (Fig. 2), and the only high score vertebrate transcription factor (TF) binding motif within this region is for HOXA3 (Fig. 2). While the reporter construct extension to the base pair 1178 did not alter the reduced promoting efficiency, the further extension to 1582 restored the reported expression to the original level (Fig. 1D). This suggests positive regulatory activity for the region 1582 to 1179. Extension of the reporter construct beyond 3000 did not significantly affect the promoter activity. The effect of the FLJ32785 intron 15 to ADAM15 promoter activity was minimal at most, consistent with the lack of conservation in the region. Altogether, the most critical ADAM15 transcription-supporting elements are located within the region 266 to 23.
###end p 33
###begin title 34
Transcription factor binding motifs in the core promoter
###end title 34
###begin p 35
###xml 66 73 66 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 469 470 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
The several transcription start sites 159 to 110 bp upstream from ADAM15 translation start indicated the location of a core promoter (Fig. 1C). The presence of several conserved TF recognition motifs in the region is consistent with the transcription start sites corroborating the core promoter location. The promoter region showed some conservation in automated sequence alignment (Fig. 1C). However, manual optimization increased the conservation significantly (Fig. 2).
###end p 35
###begin p 36
###xml 59 66 59 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 169 176 169 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">adam15 </italic>
###xml 710 711 710 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
###xml 119 122 <span type="species:ncbi:10116">rat</span>
###xml 350 355 <span type="species:ncbi:9606">human</span>
###xml 446 451 <span type="species:ncbi:9606">human</span>
###xml 456 459 <span type="species:ncbi:10116">rat</span>
###xml 648 653 <span type="species:ncbi:9606">human</span>
###xml 698 703 <span type="species:ncbi:10090">mouse</span>
The high-score vertebrate TF binding motifs found in human ADAM15 promoter sequence and in the corresponding mouse and rat sequences are shown in Figure 2. The putative adam15 promoter lacks the TATA and CAAT boxes also in rodents, and contains conserved binding sequences for five Sp1/GC-box recognition sites in all three species. In addition, the human sequence contains a sixth Sp1 motif, a Pax-4 motif, and a composite Sp1/MyoD element. The human and rat genes contain a binding sequence for Engrailed 1 (En-1) at a separate but close location upstream of the Sp1/GC boxes. The nearby upstream region contains also a HOXA3 binding sequence in human and an Aml-1 and C/EBP binding sequences in mouse (Fig. 2).
###end p 36
###begin title 37
Potential regulatory regions outside the core promoter
###end title 37
###begin p 38
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 114 117 114 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
###xml 22 25 <span type="species:ncbi:10116">rat</span>
The human, mouse, and rat ADAM15 genes were subjected to phylogenetic footprinting in order to localize potential cis-regulatory elements outside the core promoter. Sequence conservation analysis (Fig. 1C, upper panel, and data not shown) was complemented with a search for clusters of conserved TF recognition motifs, which would indicate locations of potential extra-core promoter regulatory elements (Fig. 1C, lower panel).
###end p 38
###begin p 39
###xml 170 175 170 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B, C</xref>
###xml 268 275 268 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
In all three species, the FLJ32785 intron 15 consists mostly of repetitive sequence with only short conserved elements lacking TF binding motif clusters in between (Fig. 1B, C). Consistently, reporter experiments showed that FLJ32785 intron 15 does not contain strong ADAM15 promoter activity-regulating elements.
###end p 39
###begin p 40
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
The most prominent conserved non-coding ADAM15 regions were found in introns 1 and 2. Intron 1 region 3684 to 4228 and intron 2 region 4803 to 5244 are conserved across all three species and contain several conserved TF recognition motifs which are more tightly clustered in the intron 2 region (Fig. 1C). The conserved regions do not contain long open reading frames nor were corresponding transcribed sequences found from the GenBank, suggesting that the intronic conservation is not due to transcription of another gene.
###end p 40
###begin p 41
###xml 237 244 237 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 329 336 329 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
Also the introns flanking the alternatively used exons contain obvious conserved regions. The low number of Match- and Consite-predicted TF binding sites suggests other potential role for these sequences from transcription regulation of ADAM15 or the downstream EFNA4. These regions might be conserved due their possible role in ADAM15 splicing or in the regulation of alternative splicing. Conservation in the introns flanking alternatively used exons has been reported also for other genes [25].
###end p 41
###begin p 42
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
###xml 198 203 <span type="species:ncbi:10090">mouse</span>
The human and mouse introns 3, 6, 10, 15, and 16 contain repetitive elements at corresponding locations, but only four of these 20 elements show conservation also in the type and sequence (Fig. 1B, mouse repeats not shown). Sine or Mir repetitive elements were not detected in the introns with long conserved regions or introns containing CpG-islands, as if their insertion would not have been tolerated.
###end p 42
###begin title 43
###xml 6 13 6 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 46 51 <span type="species:ncbi:9606">human</span>
Three ADAM15 exons are used differentially in human tissues
###end title 43
###begin p 44
###xml 45 52 45 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 282 283 282 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 295 296 295 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 419 420 419 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 444 445 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 502 509 502 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 588 589 588 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 39 44 <span type="species:ncbi:9606">human</span>
In addition to the previously reported human ADAM15 transcripts, nine novel mRNA variants were identified after the cloning and sequencing of over 100 reverse transcription-PCR (RT-PCR) products. The variants result from alternative use of the exons 19, 20, and 21 (Additional file 1, Figs. 1A, 3, 4). Two of these exons are alternatively spliced at one end, giving rise to the exon variants 20a/20b and 21a/21b (Figs. 1 and 4, Additional file 1). The exons 1-18, 22, and 23 were found in all examined ADAM15 transcripts, indicating that they are constitutively used. The variant 9 (Fig. 3) was not confirmed by sequencing but was indicated by the consistent appearance of the predicted size fluorescence PCR (fPCR) product and by RT-PCR amplification with a primer specific for the exon-exon junction 18/21 (data not shown). The sequences were submitted to GenBank [GenBank: , GenBank: -, GenBank: ].
###end p 44
###begin p 45
###xml 16 23 16 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 537 544 537 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 1078 1085 1078 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 1197 1204 1197 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 1280 1283 1280 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBP</italic>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 576 581 <span type="species:ncbi:9606">human</span>
The alternative ADAM15 exon use in human tissues. (A) Schematic representation of the identified human ADAM15 mRNA variants. For clarity, only the cytosolic-encoding region containing the alternatively used exons is shown. The solid connecting lines indicate splicing of the constitutive exons and the dashed connecting lines indicated splicing of the alternatively used exons. The exons are shown as black boxes, with gray shading indicating the alternative 5'- and 3'-ends of the a/b variants of the exons 20 and 21, respectively. (B) ADAM15 mRNA variant profiles in normal human tissues, detected with fluorescence-PCR/capillary electrophoresis. The relative abundance of the mRNA variants (columns) within given tissue (rows) is indicated with the color coding. Black indicates relative abundance below 0.2% and colors from blue through yellow to bright red show the relative abundances from 0.2 to 88% (see the color key bar). The bottom row shows the average of the relative abundances in all examined tissues. (C) Real-time PCR (LightCycler) quantitation (solid bars) of ADAM15 expression level and that defined with fPCR/capillary electrophoresis as the combined peak area of all detected ADAM15 cDNA variants within given samples (open bars). The vertical axis shows the TBP-normalized expression levels relative to thymus (the lowest tissue expression, value set to 1.0). The similarity of the tissue distribution (Pearson correlation 0.902) determined with the two methods indicates that significant amounts of possible additional mRNA variants were not missed with the fPCR/capillary electrophoresis detection.
###end p 45
###begin p 46
###xml 54 61 54 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 181 188 181 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 228 233 <span type="species:ncbi:9606">human</span>
###xml 1134 1139 <span type="species:ncbi:9606">human</span>
###xml 1140 1145 <span type="species:ncbi:10090">mouse</span>
Splice-regulatory motifs in the alternatively spliced ADAM15 region. Predicted alternative splicing-regulatory protein recognition motifs within and flanking the alternatively used ADAM15 exons. The exon-intron structure of the human alternatively spliced ADAM15 region is shown at the top. The exons are shown as black boxes. The exon 21b-unique 3'-region is indicated with grey. The open boxes indicate the location of the putative cryptic exons eC-19 and -20. The dashed lines indicate the possible splicings of the alternatively used exons 19-21 and solid lines indicate the constitutive splicing. For simplicity, the lines do not depict the alternative use of exon-20 5'-splice sites (differing by only three nucleotides). The alternative splicing-associated sequence motifs are indicated by the symbols explained in the key shown below the figure. The different motif classes are shown separately in the sectors indicated on the right and explained in the key. The locations of putative branch sites are indicated with the small arrows on top of the pyrimidine tracts (green bars) under the splice-regulatory motif sectors. The human-mouse sequence-conservation is visualised with mVista and PiP/BlastZ under the splice-regulatory motif panel. For easier distinction, the exonic regions are shaded in the splice-regulatory motif and sequence identity panels. Also the nucleotide numbering relative to the translation start is shown under the panels
###end p 46
###begin title 47
###xml 31 36 <span type="species:ncbi:9606">human</span>
ADAM15 mRNA variant profile in human tissues
###end title 47
###begin p 48
###xml 141 148 141 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 247 254 247 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 434 441 434 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 99 104 <span type="species:ncbi:9606">human</span>
Tissue distribution of ADAM15 mRNA variants was examined with fPCR of a cDNA panel representing 16 human tissues. Tissues showed distinctive ADAM15 variant patterns with 9 to 13 different variants at various levels (Fig. 3B). The average relative ADAM15 variant levels varied from less than 1% (variants 3b, 7a/b, 8) to 59% of the variant 2 (Fig. 3). Placenta showed the simplest and spleen and peripheral leukocytes the most complex ADAM15 variant profiles (Fig. 3B).
###end p 48
###begin p 49
###xml 32 37 <span type="species:ncbi:9606">human</span>
The exon 20a/20b usage ratio in human tissues, calculated from variants 6a/b, was on average 0.58 varying from 0.22 in skeletal muscle to 1.10 in spleen. This indicated non-constant ratio use for acceptors and that neither of the acceptor sites in the intron 19 NAGNAG was exclusively used in any examined tissue.
###end p 49
###begin p 50
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 395 402 395 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 505 512 505 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 597 604 597 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 841 843 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 26 31 <span type="species:ncbi:9606">human</span>
The ADAM15 mRNA levels in human tissues were investigated using two methods: by summing-up the mRNA variant levels determined in fPCR experiments and by the real-time quantitative PCR (qPCR) amplification of a fragment within the constantly expressed ectodomain-coding region. The tissue expression results paralleled each other (Pearson coefficient 0.902), corroborating the reliability of the ADAM15 mRNA variant profiling assay and indicating that the amplified fPCR fragments are parts of full-length ADAM15 transcripts. This also suggests that, in addition to the comparability of individual ADAM15 variant levels within given tissue, the variant levels could be comparable also between different tissues. An exception to this is the testicular expression for which no reliable housekeeping marker gene was available for normalization [26].
###end p 50
###begin title 51
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
Alternative splice-regulatory elements in the ADAM15 gene
###end title 51
###begin p 52
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 149 156 149 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 68 71 <span type="species:ncbi:9606">man</span>
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
###xml 127 132 <span type="species:ncbi:9606">human</span>
###xml 134 139 <span type="species:ncbi:10090">mouse</span>
###xml 145 148 <span type="species:ncbi:10116">rat</span>
Conservation of the alternative use of the ADAM15 exons 19 to 21 in man and mouse motivated the comparative examination of the human, mouse, and rat ADAM15 gene sequences for the identification of the sequence elements associated with the regulation of alternative splicing.
###end p 52
###begin title 53
Splice and branch sites in the alternative introns
###end title 53
###begin p 54
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 479 484 <span type="species:ncbi:9606">human</span>
Roughly half of the information for splicing has been estimated to reside in splice and branch site sequences [27,28]. The 5'ss sequences in the introns 18 (AGgtatga), 20 (AGgtaaat), and 21a (AGgtaacg) deviate from the consensus donor sequence (AGgtragt) at +4/+6, +5, and +5 positions, respectively. Also, the calculated binding energies of U1 snRNA base-pairing with these 5'ss (-4.90, -6.20, and -5.10 kcal/mol introns 18, 20, and 21, respectively) are weaker than in average human 5'ss (-6.53 kcal/mol). However, all the 5'ss-scores in the introns flanking the alternative exons are in normal range (data not shown). Intron 18 3'ss (tcatgcatagGGCAG) ASD-workbench score (3.62) and intron 19 branch site score (2.65) are low while the other 3'ss scores (7.08-9.18) and branch/pyrimidine tract scores (3.35-3.85) in the alternatively used introns are normal.
###end p 54
###begin p 55
###xml 151 152 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 277 284 277 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 271 276 <span type="species:ncbi:9606">human</span>
The second half of the information for splicing regulation is located outside of the splice and branch sites, in the exon and intron sequences. Figure 4 shows the distribution of the potential splice-regulatory factor target motifs in the alternatively spliced region of human ADAM15 gene.
###end p 55
###begin title 56
Exonic splice enhancer and silencer (ESE, ESS) sequences in alternatively used ADAM15 exons
###end title 56
###begin p 57
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 127 134 127 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 370 371 370 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 454 461 454 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 523 530 523 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 646 647 646 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 673 680 673 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 121 126 <span type="species:ncbi:9606">human</span>
Constitutive human exons typically contain three to seven Rescue-ESE clusters (average 5.2) [27]. The alternatively used human ADAM15 exons 19, 20a/b and 21a contain one/zero, one/zero, and three/six ESEs/putative exonic splice enhancers (PESE) found with the Rescue-ESE [27]/PESX [29] predictions, respectively. All ESEs and PESEs in exon 21a are in two clusters (Fig. 4). The number of ESE-finder-predicted SR-protein binding motifs in the alternative ADAM15 exons is one third lower than the average in the constitutive ADAM15 exons (data not shown). Furthermore, only three SR-protein binding motifs were localized to alternative exons (Fig. 4). Hence, the alternative ADAM15 exon splicing might be less enhanced by ESEs than the constitutive exons.
###end p 57
###begin p 58
###xml 16 23 16 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 265 272 265 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 413 420 413 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 569 570 569 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
The alternative ADAM15 exons 19, 20a/b, and 21a lack ESSs/PESSs and binding motifs for heterogeneous nuclear ribonucleoproteins (hnRNP) altogether and contain lower than average number of exonic splice-regulatory sequences (ESRs). While 12.9 ESRs were localized to ADAM15 exons on average, the alternatively used exons 19, 20a/b, and 21a contain seven, eight, and two ESRs, respectively. Despite the low usage in ADAM15 transcripts, the unique 3' part of the exon 21b contains several ESE, PESE, ESS, and ESR motifs as well as SR-protein and hnRNP binding motifs (Fig. 4).
###end p 58
###begin title 59
ESE and ESS sequences in two cryptic ADAM15 exons
###end title 59
###begin p 60
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
The GenBank EST sequences indicate locations for two rarely used cryptic exons within introns 19 and 20, referred to as eC-19 and eC-20 (for cryptic exon) (Fig. 4). Both cryptic exons contain several exonic splicing enhancer and silencer motifs (ESEs/PESEs and ESSs/PESSs). Transcripts containing these exons were not detected with exon specific primers in RT-PCR or fPCR, suggesting that they are not functional exons.
###end p 60
###begin title 61
ESSs, ESEs, hnRNP and SR-protein target motifs, and introninc splice enhancers (ISE) in the alternative ADAM15 introns
###end title 61
###begin p 62
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
In contrast to the alternative exons, the introns flanking them were rich in ESEs and ESSs as well as in hnRNP and SR-protein binding motifs (Fig. 4). The intron 19 contains several hnRNP H/F binding motifs and the intron 20 especially many conserved SRp20, SRp30b, SRp40, hnRNP F/H, and hnRNP B/D/E binding motifs. Conserved hnRNP H/F binding motifs are present near the intron 21a ends. Furthermore, several G- and C-rich ISEs were scattered throughout the alternative introns. The number of the G- and C-rich ISEs parallel the high guanine and or cytosine content, respectively, in the introns 18-21.
###end p 62
###begin title 63
Alternative splice regulation-associated motifs in the alternatively spliced ADAM15 region
###end title 63
###begin p 64
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 201 202 201 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 573 579 573 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15</italic>
###xml 567 572 <span type="species:ncbi:9606">human</span>
The four most significantly alternative splicing-associated upstream sequence motifs (AUGCAU, CUGCUA, GCAUGC, and UGCAUG) predicted in Brudno et al. [30] were found in ADAM15 alternative introns (Fig. 4). Of the predicted motifs, GCAUGC and UGCAUG contain a recognition sequence (GCAUG) for Fox-family alternative splicing regulator proteins [31]. The intron 18 contains an AUGCAU and CUGCUA motifs close to the 3'- and 5'ss, respectively. 2/2, 2/2, and 0/1 GCAUGC/UGCAUG motifs are in central location in the introns 19, 20, and 21, respectively. In addition to the human ADAM15, six of the eleven corresponding motifs are present also in at least either one of the rodents.
###end p 64
###begin p 65
###xml 242 243 242 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 697 698 697 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 899 906 899 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 398 403 <span type="species:ncbi:10090">mouse</span>
###xml 411 414 <span type="species:ncbi:10116">rat</span>
###xml 572 577 <span type="species:ncbi:9606">human</span>
###xml 579 582 <span type="species:ncbi:10116">rat</span>
###xml 587 592 <span type="species:ncbi:10090">mouse</span>
###xml 816 821 <span type="species:ncbi:10090">mouse</span>
###xml 893 898 <span type="species:ncbi:9606">human</span>
###xml 984 989 <span type="species:ncbi:10090">mouse</span>
###xml 993 996 <span type="species:ncbi:10116">rat</span>
Binding motifs for the neuronal splice-enhancer Nova-1/2 were located in the introns 18, 19, and 20 (four, one, and four, respectively). Five out of nine Nova-binding motifs were found in the corresponding location also in both rodents (Fig. 4). The exon 19 contains one and the intron 19 three binding motifs for the CELF/BrunoL family proteins. Corresponding intronic motifs were found also from mouse and/or rat. Muscleblind-like protein 1 (MBNL1) binding motifs were found in the exon 20 and in the introns 20 and 21. The exonic MBNL1 binding sequence is conserved in human, rat and mouse. Exon skipping-associated C-rich or G-rich motifs [32] were located in the introns 18, 19, and 21 (Fig. 4). The intron 18 G-rich motif is present also in both rodents and the first motif in the intron 21 is present also in mouse. Altogether 62% of the alternative splicing associated elements in the human ADAM15 exon 18 to intron 21 region were found also at the corresponding positions in mouse or rat, 34% being present in all three species.
###end p 65
###begin title 66
Deduced cytosolic ADAM15 isoform tails contain different sets of potential SH3-interaction motifs
###end title 66
###begin p 67
###xml 18 25 18 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 276 283 276 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 444 445 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
All characterized ADAM15 mRNA variants encode common ectodomain and transmembrane parts, and vary only at their cytosolic-encoding region. Variants encoding isoforms without the transmembrane part were not detected. Depending on the presence of the first alternative exon 19, ADAM15 mRNA variants are translated along either of the two alternative reading frames in the cytosolic-encoding region, downstream of exon 18 (Fig. 5, Additional file 1).
###end p 67
###begin p 68
###xml 54 61 54 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 48 53 <span type="species:ncbi:9606">human</span>
The cDNA sequence and amino acid translation of human ADAM15 alternatively spliced cytosolic tail-encoding region. The horizontal lines indicate the exon/intron boundaries. The a and b forms of the exon 20 differ by three nucleotides shown in bold. The adenylation signal is shown in bold. The start of the exon 21b-unique region is indicated with 21b. The upper translation corresponds to the mRNA variants containing the exon 19 and the lower translation corresponds to the alternative variants without the exon 19. The last amino acid encoded by the exons 18 and 19 depends on the next joined exon; both translations are shown separated by a slash. The transmembrane sequence is boxed. The putative SH3 domain-binding motifs (+XXPXXP and PXXPX+) in translations are underlined with solid line, and WW binding motifs (PPLP and PPR) with dashed line (P, proline; X, any amino acid; +, arginine or lysine). The putative NMD-targeting inframe stop codons are circled.
###end p 68
###begin p 69
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 645 652 645 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 719 720 719 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 927 928 927 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1021 1022 1021 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
The variants 2, 4a/b, 5, 6a/b, 7a/b, and 8 with exon 19 (Fig. 3A) are translated along the first reading frame after exon 19 (Fig. 5). Since the first reading frame is open and the lengths of the alternative exons 20a, 20b, or 21a (72 nt, 75 nt, and 72 nt, respectively) are divisible by three, their inclusion does not change the reading frame and their alternative use changes the ADAM15 cytosolic tail in modular fashion. Therefore the deduced protein isoforms either contain or lack the segments encoded by these exons while the carboxyl end is invariable. The first reading frame contains an inframe stop codon in the exon 21b and thus the ADAM15 variants 7a/b and 8 (Fig. 3B) encode truncated tail isoforms (Fig. 5). The variants with the exon 19, translated along the first reading frame, contain up to seven PxxP-type Src-homology-3 (SH3)-binding motifs in five separate proline clusters in their cytosolic tails (Fig. 5). The proline clusters are encoded by the exons 19, 20a/b, 21a and the 22/23 junction (Fig. 5).
###end p 69
###begin p 70
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 244 245 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
The ADAM15 variants lacking the exon 19 (1, 3a/b, and 9) are translated along the second reading frame downstream of the exon 18. Along this frame, exons 20a/b (variants 3a/b, Fig. 3B) encode also a proline cluster with SH3-binding motif (Fig. 5); ADAM15 isoforms (3a/b) containing this motif appear to show different SH3 protein interactions from those of isoforms translated along the first reading frame (our unpublished results). The variants 1 and 9 do not encode known SH3 interaction motifs.
###end p 70
###begin p 71
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 255 262 255 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
The ADAM15 variants 7a/b, 8, and 9 are predisposed to nonsense mediated mRNA decay (NMD) pathway since they contain an inframe stop codon further than 55 nt upstream of exon-exon junctions 21b-22 and/or 22-23. This suggests that proteins encoded by these ADAM15 variants would not likely be produced at high level, consistent with their low mRNA levels (Fig. 3). The variants 1, 3a, and 3b contain an inframe stop codon at exon 22 only 16 nucleotides upstream of the last exon-exon junction and are thus not likely to be targeted to NMD.
###end p 71
###begin title 72
ADAM15 comprises a subgroup with ADAMs 8, 9, 12, 19, and 28
###end title 72
###begin p 73
###xml 211 216 211 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM </italic>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 80 85 <span type="species:ncbi:9606">human</span>
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
The ADAM15 exon-intron organization and protein sequence were compared to other human and mouse ADAMs and nematode ADAM14. Based on genomic and protein sequence similarities, ADAMs fell into 13 subfamilies. The ADAM exon-intron structures and a phylogenetic tree depicting the amino acid sequence similarities of the deduced ADAM proteins are shown in Figure 6.
###end p 73
###begin p 74
###xml 670 677 670 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 744 751 744 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM33 </italic>
###xml 756 757 756 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">9</italic>
###xml 860 867 860 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM12 </italic>
Schematic presentation of aligned ADAM proteins and gene structures. (A) Schematic presentation of aligned ADAM proteins arranged into 13 subgroups according to similarities in protein sequence and gene structure. The schematic structure at the top shows the ADAM domain structure: Pre, Pro, MP, DI, ACR, EGF, TM, and CT denote the pre-, pro-, metalloprotease, disintegrin, ADAM cysteine-rich, EGF-like, and transmembrane domains, and the cytosolic tail. The intron locations are shown by the vertical lines with none to two crossing tilted lines indicating the intron phase 0, 1, or 2, respectively. The alternatively used exons within the cytosolic-encoding region of ADAM15 are indicated with blue. The alternatively used exons 17 and 18 of ADAM33 and -9, respectively, are indicated with red. The alternative last exon used in the soluble isoform-encoding ADAM12 is indicated by the letter A. Regional differences in the number of amino acids within ADAM subgroup alignment are indicated by asterisks. The location of intact metalloprotease active sites and the disintegrin loop are indicated with letters H and D, respectively. (B) Cytosolic tail-encoding gene structures of ADAMs. Alternative exon use is indicated with blue. (C) Phylogenetic tree depicting the amino acid sequence-similarities between the ADAM proteins.
###end p 74
###begin p 75
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM</italic>
###xml 186 193 186 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 225 230 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM </italic>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 458 465 458 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 499 503 499 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM</italic>
The overall ADAM15 exon-intron structure is most similar to ADAMs 8, 9, 12, 19, and 28. The intron/exon structure of the extracellular (ectodomain) and transmembrane encoding regions in ADAM15 is highly similar to that in 12 ADAM gene family members (Fig. 6A). In contrast to the ectodomain, the structure of cytosolic-encoding gene region varies greatly between different ADAMs, and only five ADAMs show intron phases and locations partially conserved with ADAM15 in cytosolic-encoding region. The ADAMs 8, 9, 12, 19, and 28 share 3, 3, 4, 3, and 3 introns with conserved phase and location, respectively. Also at the protein sequence level, ADAM15 is most similar to ADAMs 8, 12, 13, 19, and 28. ADAM9 shows similarity with ADAM15 at cytosolic tail sequence (data not shown) as well as in the gene structure encoding it.
###end p 75
###begin p 76
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 87 94 87 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 151 155 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM</italic>
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM</italic>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 378 389 378 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. elegans </italic>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 71 76 <span type="species:ncbi:9606">human</span>
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
###xml 378 388 <span type="species:ncbi:6239">C. elegans</span>
###xml 392 398 <span type="species:ncbi:9606">humans</span>
###xml 679 684 <span type="species:ncbi:10090">mouse</span>
###xml 688 691 <span type="species:ncbi:9606">man</span>
ADAM15 differs from other ADAM genes by three notable features. First, human and mouse ADAM15 lack an intron present in almost all other multiple-exon ADAM-genes (intron 14 of other ADAMs, Fig 6A). Another difference is the absence of a part of the exon 17 (Fig. 6A) which encodes a conserved membrane-proximal ADAM-specific protein motif, present in the majority of ADAMs from C. elegans to humans. This exon segment is absent also from ADAMs -7, -8, -28, -10, and -17. Third, ADAM15 is the only ADAM, in addition to ADAM22 [33], with conserved alternative splicing in cytosolic-encoding exons. In other ADAMs alternative use of cytosolic-encoding exons is restricted to either mouse or man (Fig. 6B).
###end p 76
###begin title 77
Discussion
###end title 77
###begin p 78
###xml 52 59 52 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 193 200 193 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 271 278 271 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 176 181 <span type="species:ncbi:9606">human</span>
###xml 290 295 <span type="species:ncbi:9606">human</span>
This report describes characterization of the human ADAM15 gene and promoter, comparative analysis of potential transcriptional and alternative splicing-regulatory elements in human and rodent ADAM15 genes, and the first demonstration of complex differential alternative ADAM15 splicing in human tissues.
###end p 78
###begin p 79
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15</italic>
###xml 111 118 111 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 211 216 211 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM </italic>
###xml 228 233 228 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM </italic>
###xml 314 321 314 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 413 420 413 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 503 510 503 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 570 577 570 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 151 156 <span type="species:ncbi:9606">human</span>
###xml 353 358 <span type="species:ncbi:9606">human</span>
###xml 464 469 <span type="species:ncbi:9606">human</span>
ADAM15, or its chromosomal neighborhood, appears to have been under selection pressure towards shorter length. ADAM15 gene is one third of the average human gene length [34,35] and the shortest of multiple-exon ADAM genes (some ADAM genes contain only one uninterrupted open reading frame). Although the number of ADAM15 exons is two and half times the human average and the exons are of normal size, the average ADAM15 intron length is less than one tenth of the human average [36]. The length of some ADAM15 introns is close to the theoretical minimum [37]. Moreover, ADAM15 appears to have lost an intron which is present in other ADAM genes.
###end p 79
###begin p 80
###xml 73 79 73 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15</italic>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 346 353 346 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 67 72 <span type="species:ncbi:9606">human</span>
###xml 135 140 <span type="species:ncbi:10090">mouse</span>
The present results indicate several transcription start sites for human ADAM15, in contrast to the single start site reported for the mouse gene [20]. Their location suggested the promoter position within a CpG island proximal to the translation start, which was confirmed by the reporter expression experiments. The wide tissue distribution of ADAM15 expression is consistent with the CpG-rich promoter type [38]. Consistent with the presence of multiple transcription starts, the promoter lacks CAAT and TATA boxes, and contains a cluster of conserved Sp1/GC-box motifs.
###end p 80
###begin p 81
###xml 100 107 100 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
While significant extra-promoter transcriptional regulatory elements were not found upstream of the ADAM15 promoter, the introns 1 and 2 contain highly conserved regions with clusters of conserved regulatory motifs. These could contribute to the transcriptional regulation since genomic sequence conservation is considered to indicate purifying selection and thus functional importance [39,40]. Alternatively, these regions could play a role in the splicing of the exons 2 or 3. Since the intronic splice-regulatory elements typically lie within 200 bp from exons [41], the central location of the conserved region in the intron 1 argues against a role in splicing whereas the conserved intron 2 region adjacent to exon 3 could be associated with its splicing. A third alternative explanation, that these regions were regulatory or coding parts of a gene in the complementary strand, is unlikely since no evidence was found for a complementary gene. The possible role of these conserved regions remains elusive.
###end p 81
###begin p 82
###xml 18 25 18 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 223 230 223 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 305 312 305 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 418 425 418 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 691 698 691 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 717 724 717 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 159 164 <span type="species:ncbi:9606">human</span>
###xml 343 348 <span type="species:ncbi:9606">human</span>
###xml 362 367 <span type="species:ncbi:10090">mouse</span>
###xml 475 480 <span type="species:ncbi:9606">human</span>
The expression of ADAM15 appears to be remarkably regulated at the post-transcriptional level. For the first time, the present results demonstrate that normal human tissues display different complex patterns of at least 13 ADAM15 variants. Yamamoto and coworkers have earlier demonstrated the presence of ADAM15 mRNA variants corresponding to human v5 and v6 in mouse cell lines and some tissues [20,21]. The shortest ADAM15 variant (v1) has also been reported from cultured human cells [22]. Here, the fPCR method enabled identification of several novel variants as well as more precise and quantitative examination of the variant profiles. Otherwise the studies so far have considered the ADAM15 variant 2 as "the" ADAM15 and potential contribution of other variants has not been addressed.
###end p 82
###begin p 83
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
All permutations of the alternative ADAM15 exons were not detected, suggesting that certain exon combinations are not generated or that they are unstable. The low levels of some variants might at least partially be due to their potential susceptibility to NMD, since their translation stop codon is located further than 55 nt upstream from an exon-exon junction [42]. Consistently, the variants 7a/b, 8, and 9, containing a potential NMD-targeting stop codon in the exon 21, were detected at very low levels. Variants lacking the exon 19 and containing the 21b, which would also contain a potential NMD-targeting stop codon, were not detected. In contrast, the stop codon in variants 1 and 3 is located only 16 nt upstream of the exon 22/23 junction and thus these variants should not be targeted to NMD. Correspondingly, the variant 1 was detected in several tissues at relatively high levels. The low level of variants 3a/b suggests that transcripts containing the exon 20a/b as the only alternatively used exon might not be efficiently generated.
###end p 83
###begin p 84
###xml 119 126 119 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 447 454 447 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 273 279 <span type="species:ncbi:9606">humans</span>
###xml 430 435 <span type="species:ncbi:9606">human</span>
Chance skipping of exons with weak splice signals could as such lead to complex splice patterns. However, the distinct ADAM15 splice variant patterns in cell lines and tissues indicate stringent regulation by specific factors. Alternative use of the corresponding exons in humans and rodents indicates at least some conservation of regulatory mechanisms, which should appear as conserved elements in the gene sequence. Hence, the human and rodent ADAM15 genes were comparatively examined for conserved alternative splicing-associated sequence motifs.
###end p 84
###begin p 85
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 728 730 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 874 876 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
Splicing is primarily regulated through modulation of splice and branch site recognition and subsequent spliceosome assembly [43-45]. The binding strength of U1, U2AFs, and U2 snRNPs to their complementary sequences determines how easily the splice and branch sites will be skipped. This is further controlled by regulatory proteins which either facilitate or suppress the splice site selection depending on the type of the binding protein and the location of the binding site. The regulatory motifs are classified into exonic and intronic splice enhancers (ESE, ISE) and silencers (ESS, ISS) [46]. However, this nomenclature is not unambiguous; e.g., an ESS can enhance the splice site recognition if located within an intron [47]. Also the relative location within an exon or intron can influence the mode (enhancement/suppression) or potency of some regulatory elements [48].
###end p 85
###begin p 86
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 410 417 410 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 669 676 669 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
The alternatively used ADAM15 exons appear to lack strong exon definition. Weak splice donor and branch sites, atypical 5'ss sequences, in particular a non-consensus nucleotide at +5 position, and low ESE numbers have been associated with alternative exon use [27,30,49-51]. Thus the weak 5' splice and branch sites, substitution of the +5 g in the 5'ss, and the scarcity of ESEs indicate that the alternative ADAM15 exons might be predisposed to skipping due to little exonic splice enhancement and inefficient splice site recognition. On the other hand, they are almost devoid of exonic suppression elements, i.e. ESS and hnRNP binding motifs. Hence, the alternative ADAM15 splicing is likely not controlled through exonic but rather through intronic motifs, consistently with the abundance of splice enhancer and repressor motifs in the flanking introns.
###end p 86
###begin p 87
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 778 780 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1076 1083 1076 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
The available data do not allow prediction of the exact regulatory role of individual motifs but some suggestions can be made based on their location, type, and conservation. The hnRNPs have been shown to regulate alternative splicing through competitive pre-mRNA binding [44,45,52,53]. The conserved hnRNP I binding motifs in the intron-18 pyrimidine tract close to the U2AF site and the hnRNP H/F and B/D/A0 binding motifs close to the 5'ss in introns 21a and 21b, respectively, are potential splice-regulatory sites for which the hnRNP might compete. The hnRNPs have also been suggested to regulate alternative splicing through RNA loop-out mechanisms, in which homotypic interaction of pre-mRNA-bound hnRNPs enhances the use of splice sites by bringing them into proximity [54]. On the other hand, the model posits that if the looped-out RNA segment includes splice site(s), the corresponding exon would be skipped. The number and location of hnRNP H/F binding motifs in introns 19, 20, and 21 suggest that a looping-out mechanism may regulate splicing of the alternative ADAM15 exons 20 and 21.
###end p 87
###begin p 88
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 813 815 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
The introns flanking the alternatively used ADAM15 exons contain several ESEs, SR-protein binding motifs, and ESSs possibly regulating the splice site use. The ESEs and SR-protein binding to motifs near the branch sites in the introns 19 and 20 may affect the downstream exon splicing via regulating branch site and 3'ss complex formation [44,55]. The SR-binding motifs just downstream of the exons 18, 19, and 21 could enhance their splicing by facilitating U2, U2AF, and U1 binding [56]. ESEs and SR-binding motifs in the unique region of exon 21b might enhance the distal 5'ss use. However, the ESSs in this region might enhance the selection of weak intron 21a 5'ss over the downstream 21b 5'ss. This could suppress the exon 21b use, as suggested by a recent study of the general role of intronic ESS motifs [47].
###end p 88
###begin p 89
###xml 21 23 21 23 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 531 538 531 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
Fox-family proteins [57] are obvious candidate regulators of alternative ADAM15 splicing, suggested by the conserved Fox-binding motifs in the introns 19, 20, and 21. The Fox proteins have been shown to specifically affect the alternative splicing of their targets in several tissues [31,58-65]. Fox-binding elements have been shown to function as downstream splice enhancers or upstream silencers in mammals [65], and it remains to be elucidated which Fox-intron interactions might regulate the alternative splicing of individual ADAM15 exons.
###end p 89
###begin p 90
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 199 206 199 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 354 361 354 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 256 261 <span type="species:ncbi:9606">human</span>
###xml 266 269 <span type="species:ncbi:10116">rat</span>
The CUGCUA and AUGCAU motifs have also been associated with alternative splicing [30] although their cognate regulatory proteins have not been identified. Their location close to the 5'- and 3'ss in ADAM15 intron 18, and conservation of the CUGCUA between human and rat, suggest that these motifs might contribute to the regulation of alternative use of ADAM15 exon 19.
###end p 90
###begin p 91
###xml 74 81 74 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 469 476 469 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 564 571 564 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
Other potential intronic regulatory elements in the alternatively spliced ADAM15 region are the conserved recognition motifs for splice factors of Nova, CELF, and MBNL families. These proteins regulate alternative splicing mostly as intronic upstream splice silencers and downstream enhancers [66-69]. However, their competitive binding with any splice factors could have an effect independently of the relative exon position. The uneven distribution of motif types in ADAM15 introns suggests that each of these splice factor families could affect the splicing of ADAM15 exons differently.
###end p 91
###begin p 92
###xml 215 222 215 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 318 325 318 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 399 406 399 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 579 581 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 791 793 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 910 917 910 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 164 169 <span type="species:ncbi:9606">human</span>
###xml 460 465 <span type="species:ncbi:9606">human</span>
###xml 566 571 <span type="species:ncbi:10090">mouse</span>
Alternative exon use might provide a novel physiological mechanism for functional ADAM15 regulation. Differential splicing of the three cytosolic-encoding exons in human tissues indicates differential regulation of ADAM15 variant production. This regulation appears to be disturbed in cancer cells which show aberrant ADAM15 variant patterns [19]. However, it remains to be investigated whether the ADAM15 mRNA variants are translated into protein isoforms in human tissues. Endogenous production of a longer ADAM15 protein isoform has been demonstrated in cultured mouse cells [20]. Although the molecular function of ADAM15 is poorly understood it has been associated with e.g. cell migration. In one cell type ADAM15 enhanced cell migration [70] whereas it inhibited motility in another [71], suggesting different function in different cells. It is intriguing to speculate that the differential splicing of ADAM15 transcripts could be a regulatory mechanism for such differences.
###end p 92
###begin p 93
###xml 38 45 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 584 585 584 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 894 896 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 992 1000 992 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 640 645 <span type="species:ncbi:10090">mouse</span>
###xml 678 683 <span type="species:ncbi:9606">human</span>
###xml 828 833 <span type="species:ncbi:10090">mouse</span>
###xml 969 974 <span type="species:ncbi:9606">human</span>
An obvious consequence of alternative ADAM15 splicing is the differential propensity of ADAM15 protein isoforms to regulatory cytosolic interactions. Thus alternative splicing could affect the cytosolic regulation of ADAM15 function or subcellular targeting. The cytosolic region of the deduced ADAM15 isoforms contains different sets of recognition motifs for signaling and adaptor protein interaction domains such as SH3. Several cytosolic protein tyrosine kinases, mitotic control factors, and cytoskeletal adaptors have been shown to interact with "the" ADAM15 (i.e., isoform-2) [3,72-74]. Yamamoto and coworkers have demonstrated that mouse ADAM15 isoform corresponding to human isoform-6 bound more strongly to Src family proteins than the "normal" form (isoform-2) and this interaction was enhanced by a phorbol ester in mouse cells, a treatment known to activate ADAM metalloproteases [20,21]. Our unpublished results indicate differential SH3-interactions for human ADAM-15 isoforms in vitro.
###end p 93
###begin p 94
###xml 239 246 239 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 508 515 508 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 389 395 <span type="species:ncbi:9606">humans</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
###xml 492 497 <span type="species:ncbi:9606">human</span>
###xml 502 507 <span type="species:ncbi:10090">mouse</span>
###xml 653 658 <span type="species:ncbi:9606">human</span>
The intron/exon structure and deduced protein sequences indicate that ADAM15 comprises a subfamily with ADAMs 8, 9, 12, 19, and 28. The similarity suggests that the subfamily members may share functional and/or regulatory characteristics. ADAM15 is the only subfamily member for which the alternative use of the corresponding exons in the cytosolic-encoding region is conserved in between humans and mice. Another difference is the apparently lost intron from the ectodomain-encoding part of human and mouse ADAM15 genes. Its presence in almost all other ADAM genes indicates that this intron was deleted from an ancestral gene before the divergence of human and rodent lineages. The possible functional parallels with other subgroup members provide clues for further elucidation of the physiological and pathological roles and regulation of ADAM15.
###end p 94
###begin title 95
Conclusion
###end title 95
###begin p 96
###xml 10 17 10 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 129 136 129 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 437 444 437 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 672 679 672 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 172 177 <span type="species:ncbi:9606">human</span>
###xml 359 364 <span type="species:ncbi:9606">human</span>
###xml 431 436 <span type="species:ncbi:9606">human</span>
###xml 486 491 <span type="species:ncbi:10090">mouse</span>
###xml 496 499 <span type="species:ncbi:10116">rat</span>
###xml 690 695 <span type="species:ncbi:9606">human</span>
###xml 700 705 <span type="species:ncbi:10090">mouse</span>
The human ADAM15 gene sequence, genomic structure, and promoter were characterized. For the first time, differential alternative ADAM15 splicing was demonstrated in normal human tissues, indicating that alternative exon use is a physiological post-transcriptional mechanism regulating ADAM15 expression. The genomic exon-intron structure is identical between human and rodent genes, and the considerable sequence-similarity of the human ADAM15 promoter with the corresponding region in mouse and rat, including several conserved transcription factor recognition motifs, suggests similarities in transcriptional regulatory mechanisms. Also, the alternative use of the same ADAM15 introns in human and mouse indicates conservation of at least some mechanisms regulating alternative splicing.
###end p 96
###begin p 97
###xml 82 89 82 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 483 490 483 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 571 578 571 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
The present results provide important clues for further studies. Knowledge of the ADAM15 gene structure and transcriptional control elements are important prerequisites for better understanding of its mis-regulation in cancers and other diseases as well as for the elucidation of its physiological role. As alternative splicing is emerging as an important mechanism increasing the functional diversity of gene expression, characterization of the regulation mechanisms of alternative ADAM15 exon use will also provide novel information of alternative splicing in general. ADAM15 is particularly useful for monitoring changes in splice-regulation because the variant profiles arising from the alternative use of the three tandemly located exons can be readily examined with the straightforward and sensitive fPCR assay.
###end p 97
###begin title 98
Methods
###end title 98
###begin title 99
Cell lines
###end title 99
###begin p 100
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human cell lines HCC-1954 (ATCC CRL-2338), MDA-361 (ATCC HTB-27), HCC-202 (ATCC CRL2316), and SK-BR-3 (ATCC HTB-30) were provided by the IMT Cancer Biology Laboratory (Institute of Medical Technology, University of Tampere) and cultured according to American Type Culture Collection (ATCC) recommendations [75].
###end p 100
###begin title 101
ADAM15 gene sequencing
###end title 101
###begin p 102
###xml 25 32 25 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 264 271 264 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 566 573 566 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 77 82 <span type="species:ncbi:9606">human</span>
###xml 453 458 <span type="species:ncbi:9606">human</span>
###xml 517 522 <span type="species:ncbi:9606">human</span>
PAC clone containing the ADAM15 gene sequence was identified from an arrayed human genomic PAC-library as described in [23]. PAC-DNA was purified with Qiagen Miniprep reagents (Qiagen, Hilden, Germany) and used as the template for PCR amplification of overlapping ADAM15 gene regions. Sequencing confirmed that the PAC-clone 240C8 contains the whole ADAM15 gene region. Over 100 PCR and sequencing primers were designed based on sequence information of human ADAM15 cDNA (GenBank accessions  and ) and the unfinished human genomic sequence up- and downstream of the ADAM15 coding sequence (GenBank accession ).
###end p 102
###begin p 103
###xml 440 447 440 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 503 510 503 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 579 581 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 588 595 588 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
Amplified cDNA and gene fragments were gel-purified with MinElute gel extraction reagents (Qiagen) and directly sequenced or cloned. Sequencing was done with BigDye sequencing reagents according to the manufacturer's cycle sequencing protocol (Applied Biosystems, Foster City, CA, USA). Sequencing reactions were analysed with ABI Prism 310 and 3100 sequencers, and ABI data collection software, version 1.0.1 (Applied Biosystems). Genomic ADAM15 sequence contig was assembled and manually aligned with ADAM15 cDNA and EST sequences using the Genedoc sequence editor program [76,77]. The ADAM15 gene sequence was submitted to the GenBank [GenBank: ].
###end p 103
###begin title 104
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
ADAM15 transcription start site determination
###end title 104
###begin p 105
###xml 326 333 326 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 510 517 509 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 730 737 729 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 949 956 948 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
A successive PCR strategy was used for the transcription start site determination. Briefly, one downstream primer at a fixed position along the ADAM15 cDNA was used in PCR reactions against upstream primers, at successive positions upstream along the genomic sequence. Gene-specific cDNA template was reverse-transcribed with ADAM15 exon 5 antisense primer CCTGGTAGCAGCAGTTCTCC from 5 mug HCC-1954 and SK-BR-3 cell line total RNA with Superscript II reverse transcriptase (Invitrogen, Groningen, Netherlands). ADAM15 5'-target fragments were amplified with a common exon 2 antisense primer CTTCTCTGACTCTGCCTGCTGC paired with a series of sense primers (successively further up along the genomic sequence) that covered the putative ADAM15 promoter region and upstream region containing the last exons of the upstream-neighbour gene FLJ32785, at both transcribed and intronic positions. The upstream primers, with the genomic locations relative to the ADAM15 translation start ATG were as follows: (FLJe10/-5447) CTTCTGCCAGATCGATGACC, (FLJe15/-3338) GCGGATCCTGTTCCTCTACA, (FLJi15/-1419) AGCTCTCAGGGAGGGCTAAA, (FLJe16/-638) GTGTACTGCTGGTCGTGCTG, (FLJe16/-473) AAATGCCCTGTACGCTTCAC, (-355) GGAGGCCGCGAAGCTACTA, (-170) CTTTGCCGGGGGCGGAGCT, (e1/-159) GCGGAGCTTGGCTTGGGGC, (e1/-149) GCTTGGGGCCGGGTGGGA, (e1/-130) GGGGCGGGCCGGGGCGGGGC, (e1/-114) GGGCCTGGTGGCCGCGCG, (e1/-100) CGCGGCGCTGCTGGGTTCT, (e1/-86) GTTCTCCGAGGCGACCTG, and (e1/-1) CATGCGGCTGGCGCTGCTCT; (i and e indicate intronic and exonic hybridization sites of the primers, respectively).
###end p 105
###begin p 106
###xml 233 240 233 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
PCR reactions were carried out for 30 and 35 cycles, in the presence of 8% DMSO, and the amplified DNAs were analysed with agarose gel electrophoresis. The products clearly detectable after 30 cycles of PCR were considered as normal ADAM15 expression, and the products that appeared only after 35 PCR cycles were judged as minor forms.
###end p 106
###begin title 107
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
ADAM15 cDNA variant cloning and luciferase reporter plasmid construction
###end title 107
###begin p 108
###xml 247 249 246 248 <sub xmlns:xlink="http://www.w3.org/1999/xlink">24</sub>
###xml 316 323 315 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 481 488 480 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 725 732 724 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
Total RNA was isolated from the cultured cells using Trizol reagent with standard protocol (Invitrogen). 2 mug of total RNA from SK-BR-3, HCC-1954, MDA-361, and ZR-75-1 cells was reverse-transcribed using Superscript II reverse transcriptase and T24V-primer (V denotes any deoxynucleotide except T). The full-length ADAM15 cDNA was PCR-amplified using the primer pair GTTCTCCGAGGCGACCTG (sense e1/-86)/CGCAGAGTGTTGCTTGACAG (antisense e23/2598). Most of the cytosolic tail-encoding ADAM15 cDNAs were cloned as partial ADAM15 cDNAs with the upstream primers GGGCACAGGAATGTCGAAG (e15/1958) or GATGCTTGGTGCCAGCTACT (e18/2127) and the downstream primer CGCAGAGTGTTGCTTGACAG priming within the common 3'-untranslated region of the ADAM15 cDNA variants (e23/2598). The PCR products were gel purified and TA-cloned into topoisomerase-coupled pCRII or pCR2.1 plasmid vectors (Invitrogen). Over 100 clones containing cytosolic tail-encoding cDNA variants were sequenced.
###end p 108
###begin p 109
###xml 58 65 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 245 252 245 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 884 891 884 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 1027 1034 1027 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
For the promoter analysis constructs, six different sized ADAM15 upstream regions were inserted in forward orientation to the upstream cloning site of the enhancerless luciferase-reporter plasmid pGL2-Basic (Promega, Madison, WI, USA). Briefly, ADAM15 upstream region -3231 to -23 was amplified from the 240C8-PAC DNA with a common BamHI-overhang antisense primer AGTCGGGATCCCGAGGGCAGCAAGTGCGGAACAG and sense primers AGCAGAAGGCTCCGGTAAGT (-3231), XhoI-overhang CTGCCGCTCGAGCTGCAGGAACATGCTGGGATTCCTTGAC (-1582), and XhoI-overhang GAACCGCTCGAGCGGACTCCGCACAGTTGCGGGGAA (-266). The BamHI- and XhoI-primer restriction sites and the native sites XhoI, ApaI, and PstI were used in double digestion to produce cohesive ends for -3108/-23, -1582/-23, -266/-23, -1178/-23, and -415/-23 fragments. The restriction enzymes were purchased from Fermentas (Fermentas, Vilnius, Lithuania). The sixth ADAM15 construct (pGL2--266/-170+-121/-23) was a coincidental PCR-deletion-form found during the screen for -266/-23 promoter clones. All pGL2-ADAM15 constructs were sequenced to verify their insert sequences.
###end p 109
###begin title 110
Luciferase reporter assay
###end title 110
###begin p 111
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15</italic>
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 115 119 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
For each pGL2-ADAM15-construct, pGL2-Basic (control plasmid, luciferase without ADAM15 insert), and pGL2-Promoter (SV40 promoter), two triplicate sets of transfections were done with both SK-BR-3 and HCC-1954 cell lines. The cells were transfected with 4 mug pGL2-plasmid for each 3.2 cm well together with Lipofectamine Plus reagents (Invitrogen). The luciferase activity was measured with Promega luciferase assay according to the manufacturer's protocol (Promega, Madison, WI, USA) and 1254 Luminova luminometer (Bio-Orbit, Turku, Finland) or Luminoskan Ascent multi-plate luminometer (Thermo/Labsystems, Vantaa, Finland). The measured luciferase activities were normalized to the total protein determined with Detergent Compatible Protein Assay (Bio-Rad, Hercules, CA, USA) and Multiskan EX spectrometer (Thermo/Labsystems, Vantaa, Finland).
###end p 111
###begin title 112
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 59 64 <span type="species:ncbi:9606">human</span>
Analysis of ADAM15 expression and mRNA variant profiles in human tissues
###end title 112
###begin p 113
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 60 65 <span type="species:ncbi:9606">human</span>
###xml 135 140 <span type="species:ncbi:9606">human</span>
ADAM15 expression and alternative ADAM15 exon use in normal human tissues were studied with real-time qPCR and fPCR, respectively. The human tissue cDNAs (MTC multiple tissue panels I and II) were purchased from Clontech (Mountain View, CA, USA).
###end p 113
###begin title 114
Real-time qPCR
###end title 114
###begin p 115
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15</italic>
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBP </italic>
###xml 266 269 266 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TBP</italic>
###xml 281 288 281 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
The ADAM15-primer pair GAGAAAGCCCTCCTGGATG (forward/exon 10) and GGGCAGAATTCAGGCAAGT (reverse/exon 14) and the TBP (TATA box-binding protein)-primer pair GAATATAATCCCAAGCGGTTTG (forward) and ACTTCACATCACAGCTCCCC (reverse) were used in real-time qPCRs to examine the TBP-normalized ADAM15 expression level in the tissue samples. The reactions were done with QuantiTect SYBR Green PCR reagents (Qiagen) using LightCycler thermal cycler (Roche, Mannheim, Germany).
###end p 115
###begin title 116
Fluorescence-PCR and fragment analysis
###end title 116
###begin p 117
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 635 640 <span type="species:ncbi:9606">human</span>
ADAM15 mRNA variants were detected from the human tissue cDNAs using PCR with the 5'-6-carboxyfluorescein (FAM)-labeled forward primer CTCAGCTCAAAGCAACCAGCTG (exon 17-18) and the reverse primer GGTCTGGAGGGTACCACTAGG (exon 22-23). Amplified DNAs and ROX-1000 DNA size standard (Applied Biosystems) were diluted into HiDi formamide (Applied Biosystems), and resolved with capillary electrophoresis and detected using ABI Prism 3130 Genetic Analyzer (Applied Biosystems). This sensitive and quantitative method will be described in more detail elsewhere (Ortiz RM, Kleino I, Isola J, Huovila A-PJ: Aberrant ADAM15 alternative exon use in human breast cancer, submitted). The fragment lengths and volumes were analyzed with Applied Biosystems Genoprofiler software.
###end p 117
###begin title 118
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
ADAM15 gene sequence analysis
###end title 118
###begin p 119
###xml 68 75 68 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 282 289 282 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">adam15 </italic>
###xml 371 378 371 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">adam15 </italic>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 10 13 <span type="species:ncbi:10116">rat</span>
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 276 281 <span type="species:ncbi:10090">mouse</span>
###xml 367 370 <span type="species:ncbi:10116">rat</span>
###xml 487 492 <span type="species:ncbi:10090">mouse</span>
###xml 493 498 <span type="species:ncbi:9606">human</span>
Mouse and rat genomic and cDNA sequences corresponding to the human ADAM15 genomic region (-3231 to 11799) sequence were acquired from the GenBank using nucleotide BlastN search of the non-redundant and HTGS databases [78], and mega-BlastN for assembled genomes. The acquired mouse adam15 gene sequence was used in the overall phylogenetic footprinting analyses, and rat adam15 gene region sequence in the promoter and splice regulatory motif analyses as well as for guiding the genomic mouse/human alignment in ambiguous regions.
###end p 119
###begin p 120
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
The genomic regions were examined for repetitive sequences with the RepeatMasker program [79] and the CpG islands were detected with the CpGPlot program [80,81].
###end p 120
###begin p 121
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B82">82</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B84">84</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B85">85</xref>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B86">86</xref>
The matrix searches for transcription factor binding sites were done with the public version of Match [82] using the vertebrate TF binding site matrices of Transfac 6.0 database [83]. The cut-offs were set for the matrix similarity to 0.9 and for the core similarity to 0.9. Putative composite elements [84,85] within the promoter region were searched with the Compel Pattern Search 1.0 program [86].
###end p 121
###begin p 122
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B87">87</xref>
###xml 309 316 309 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
Phylogenetically conserved TF binding sites in the genomic sequences were searched using the Consite [87] with following settings: only vertebrate transcription factors with minimum specificity of 9 bits and transcription factor score threshold 84% were searched, conservation cut-off 50, window size 50. The ADAM15 ORF was excluded from the analysis
###end p 122
###begin p 123
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B88">88</xref>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B89">89</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B90">90</xref>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B91">91</xref>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B92">92</xref>
###xml 769 771 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B93">93</xref>
###xml 263 268 <span type="species:ncbi:9606">human</span>
###xml 270 275 <span type="species:ncbi:10090">mouse</span>
###xml 281 284 <span type="species:ncbi:10116">rat</span>
The alignment for the sequence identity visualization tool mVista [88] was done with the MAVID [89] and for the visualization tool PiP-maker [90] with the BlastZ. The alignment used in the Consite analysis was assembled manually from the initial alignment of the human, mouse, and rat genomic and cDNA sequences made with the ClustalW program [91]. The alignment was manually modified in the Genedoc program to correspond to the colinear blocks found with the Blast2 program [92]. The visual comparison of all genomic and cDNA sequences was used to guide optimal alignment of the poorly aligned regions. This alignment was later found to be very close to alignment produced with BlastZ which uses similar but fully automated alignment algorithm based on blast-program [93]. The manual alignment was used in the Consite analysis because some regions, e.g. the promoter region containing simple repeats, didn't align optimally with any of the tested automated alignment programs. The MAVID alignment was used in the mVista and rVista analyses and BlastZ alignment in the PiP-maker because these programs required the use of the accompanying alignment programs.
###end p 123
###begin p 124
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B94">94</xref>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B95">95</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B94">94</xref>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B95">95</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B96">96</xref>
The branch sites were located and scored with Branch-Site Anlyzer program implementing the algorithm described in Kol et al. [51] and with ASD-workbench [94]. The 5'- and 3'-splice site binding energies and consensus scores were determined with the Splice-Site-Analyzer developed by the Ast lab [95] and with the ASD-workbench [94]. The consensus sequences used for the branch, 5'-, and 3'-splice sites were from [95,96].
###end p 124
###begin p 125
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B97">97</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B96">96</xref>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B98">98</xref>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B99">99</xref>
###xml 349 352 349 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B100">100</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 387 390 387 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B101">101</xref>
###xml 391 394 391 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B105">105</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 421 424 421 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B104">104</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 455 458 455 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B106">106</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 490 493 490 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B107">107</xref>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 556 559 556 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B108">108</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 590 593 590 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B109">109</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 732 735 732 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B110">110</xref>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 767 770 767 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B111">111</xref>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 808 811 808 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B112">112</xref>
###xml 812 815 812 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B113">113</xref>
###xml 845 848 845 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B114">114</xref>
###xml 849 852 849 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B115">115</xref>
###xml 905 907 905 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 990 997 990 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 1031 1032 1031 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
Exonic splicing enhancer/silencer motifs were searched for with the Rescue-ESE server (ESEs) [27], the PESX-server (PESEs/PESSs) [29], the ESE-finder [97], and the ESR-search (ESRs and ESSs) [47,48]. The searched splice-regulatory motifs were collected from the literature: C-rich and G-rich ISEs [96]; GT-rich (alternative ISEs) [98]; hnRNP A1 [99,100]; hnRNP A2/B1 [45]; hnRNP B/D/A0 [101-105]; hnRNP C [45]; hnRNP D0 [104]; hnRNP H/F [44,45]; hnRNP H [106]; hnRNP I [44,45]; hnRNP L [45,107]; hnRNP M [45]; SRp20 [45]; SRp30a [45]; SRp30b [45]; Srp30c [108]; SRp40 [45]; SRp54 (AAGAAG) [109]; SRp55 [45]; 9G8 [45]; Tra2-B (GAAGAA)n [43]; UGCAUG, GCAUGC, AUGCAU, CUGCUA, [30]; Alt-ISEs UUUUUU, CUCUCU [30]; Fox-1/-2/-3 UGCAUG [31,110]; Fox-1 GCAUG [65]; Nova-1/-2 [111]; CELF/BrunoL family and (CUG)x8 [68,112,113]; MBNL1, (CCUG)n and (CUG)n [114,115]; exon skipping-associated C-rich or G-rich motifs [32]. All motifs in the articles were searched for, but only those that were found in ADAM15 gene sequence are shown in Figure 4.
###end p 125
###begin title 126
ADAM family comparison
###end title 126
###begin p 127
###xml 110 121 110 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. elegans </italic>
###xml 357 360 357 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B116">116</xref>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 92 97 <span type="species:ncbi:9606">human</span>
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
###xml 110 120 <span type="species:ncbi:6239">C. elegans</span>
For comparison of ADAM15 to other ADAM family members, the genomic and protein sequences of human, mouse, and C. elegans (ADAM14) ADAMs were retrieved from the GenBank. The protein sequences were aligned according to sequence-similarity. The correspondence of the intron locations and phases to the protein sequences was determined with the Wise 2 program [116] and checked manually. ADAMs were divided into subgroups based on the similarity of the genomic structure and protein sequence. A phylogenetic tree depicting the amino acid sequence-similarities of the ADAM proteins was built in the Clustal X and visualized with the Unrooted (Fig. 6C).
###end p 127
###begin title 128
Authors' contributions
###end title 128
###begin p 129
IK carried out the cloning, sequencing, reporter expression, and PCR experiments, the sequence analyses, and initial drafting of the manuscript. RO participated in the set-up of the fPCR/capillary electrophoresis experiments, data analysis, and contributed to the manuscript. AH participated in the planning of the study and finalization of the manuscript. All authors read and approved the final manuscript.
###end p 129
###begin title 130
Supplementary Material
###end title 130
###begin title 131
Additional file 1
###end title 131
###begin p 132
###xml 38 45 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADAM15 </italic>
###xml 32 37 <span type="species:ncbi:9606">human</span>
Exon-intron organization of the human ADAM15 gene. The exon sequences are shown in upper case (the middle column) and the introns in lower case (the right and left columns). The location of the first and last nucleotides of the introns, relative to the translation start adenine, are indicated above the sequences. The intron lengths and phases are shown in the right columns. The first and last exon nucleotides are numbered according to their location in the coding DNA sequence (CDS). The amino acid translation is shown under the exon sequence. The non-consensus nucleotides around the splice sites are colored red (a purine (R) instead of a consensus pyrimidine (Y) or vice versa) and blue (no R/Y change).
###end p 132
###begin p 133
Click here for file
###end p 133
###begin title 134
Acknowledgements
###end title 134
###begin p 135
This study was supported by research grants from the Medical Research Fund of Tampere University Hospital. IK was partially supported by a fellowship of Tampere Graduate School in Biosciences and Biomedicine, and grants from the Finnish Cultural Foundation, Pirkanmaa Regional Fund of the Finnish Cultural Foundation, Emil Aaltonen Foundation, and University of Tampere. R.O. was partially supported by grants from University of Tampere, Ida Montin Foundation, and Finnish Cultural Foundation. We wish to thank Anni Kleino for her helpful comments on the manuscript.
###end p 135
###begin article-title 136
Metargidin, a membrane-anchored metalloprotease-disintegrin protein with an RGD integrin binding sequence
###end article-title 136
###begin article-title 137
ADAMs: modulators of cell-cell and cell-matrix interactions
###end article-title 137
###begin article-title 138
The ADAMs family of metalloproteases: multidomain proteins with multiple functions
###end article-title 138
###begin article-title 139
ADAMs: key components in EGFR signalling and development
###end article-title 139
###begin article-title 140
Shedding light on ADAM metalloproteinases
###end article-title 140
###begin article-title 141
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Potential role for ADAM15 in pathological neovascularization in mice
###end article-title 141
###begin article-title 142
Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands
###end article-title 142
###begin article-title 143
Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin
###end article-title 143
###begin article-title 144
Expression of ADAM15 in rheumatoid synovium: up-regulation by vascular endothelial growth factor and possible implications for angiogenesis
###end article-title 144
###begin article-title 145
Melanoma cell-derived vascular endothelial growth factor induces endothelial tubulogenesis within fibrin gels by a metalloproteinase-mediated mechanism
###end article-title 145
###begin article-title 146
Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3
###end article-title 146
###begin article-title 147
###xml 53 58 <span type="species:ncbi:9606">human</span>
Expression of a disintegrin-like protein in cultured human vascular cells and in vivo
###end article-title 147
###begin article-title 148
###xml 82 87 <span type="species:ncbi:9606">human</span>
Altered expression of ADAMs (A Disintegrin And Metalloproteinase) in fibrillating human atria
###end article-title 148
###begin article-title 149
###xml 53 58 <span type="species:ncbi:9606">human</span>
Up-regulation of MDC15 (metargidin) messenger RNA in human osteoarthritic cartilage
###end article-title 149
###begin article-title 150
Highly enhanced expression of the disintegrin metalloproteinase MDC15 (metargidin) in rheumatoid synovial tissue
###end article-title 150
###begin article-title 151
The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer
###end article-title 151
###begin article-title 152
###xml 76 81 <span type="species:ncbi:9606">human</span>
Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy
###end article-title 152
###begin article-title 153
ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease
###end article-title 153
###begin article-title 154
###xml 59 64 <span type="species:ncbi:9606">human</span>
Aberrant alternative exon use and increased copy number of human metalloprotease-disintegrin ADAM15 gene in breast cancer cells
###end article-title 154
###begin article-title 155
###xml 32 38 <span type="species:ncbi:10090">murine</span>
Structure and expression of the murine ADAM 15 gene and its splice variants, and difference of interaction between their cytoplasmic domains and Src family proteins
###end article-title 155
###begin article-title 156
###xml 37 42 <span type="species:ncbi:9606">human</span>
Expression of splice variants of the human ADAM15 gene and strong interaction between the cytoplasmic domain of one variant and Src family proteins Lck and Hck
###end article-title 156
###begin article-title 157
###xml 34 39 <span type="species:ncbi:9606">human</span>
ADAM-15 inhibits wound healing in human intestinal epithelial cell monolayers
###end article-title 157
###begin article-title 158
###xml 33 38 <span type="species:ncbi:9606">human</span>
Assignment of the ADAM15 gene to human chromosome band 1q21.3 by in situ hybridization
###end article-title 158
###begin article-title 159
Widespread occurrence of alternative splicing at NAGNAG acceptors contributes to proteome plasticity
###end article-title 159
###begin article-title 160
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
Intronic sequences flanking alternatively spliced exons are conserved between human and mouse
###end article-title 160
###begin article-title 161
High accumulation of components of the RNA polymerase II transcription machinery in rodent spermatids
###end article-title 161
###begin article-title 162
###xml 58 63 <span type="species:ncbi:9606">human</span>
Predictive identification of exonic splicing enhancers in human genes
###end article-title 162
###begin article-title 163
A computational analysis of sequence features involved in recognition of short introns
###end article-title 163
###begin article-title 164
Computational definition of sequence motifs governing constitutive exon splicing
###end article-title 164
###begin article-title 165
Computational analysis of candidate intron regulatory elements for tissue-specific alternative pre-mRNA splicing
###end article-title 165
###begin article-title 166
A vertebrate RNA-binding protein Fox-1 regulates tissue-specific splicing via the pentanucleotide GCAUG
###end article-title 166
###begin article-title 167
Conserved sequence elements associated with exon skipping
###end article-title 167
###begin article-title 168
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice
###end article-title 168
###begin article-title 169
###xml 39 44 <span type="species:ncbi:9606">human</span>
Initial sequencing and analysis of the human genome
###end article-title 169
###begin article-title 170
###xml 33 38 <span type="species:ncbi:9606">human</span>
The DNA sequence and analysis of human chromosome 14
###end article-title 170
###begin article-title 171
###xml 29 39 <span type="species:ncbi:10116">Norway rat</span>
Genome sequence of the Brown Norway rat yields insights into mammalian evolution
###end article-title 171
###begin article-title 172
Alternative pre-mRNA splicing: the logic of combinatorial control
###end article-title 172
###begin article-title 173
Structure, function and evolution of CpG island promoters
###end article-title 173
###begin article-title 174
Conserved noncoding sequences are reliable guides to regulatory elements
###end article-title 174
###begin article-title 175
Comparative genomics
###end article-title 175
###begin article-title 176
###xml 64 69 <span type="species:ncbi:9606">human</span>
Distribution and characterization of regulatory elements in the human genome
###end article-title 176
###begin article-title 177
New insights into the formation of active nonsense-mediated decay complexes
###end article-title 177
###begin article-title 178
Sorting out the complexity of SR protein functions
###end article-title 178
###begin article-title 179
Mechanisms of alternative pre-messenger RNA splicing
###end article-title 179
###begin article-title 180
Building specificity with nonspecific RNA-binding proteins
###end article-title 180
###begin article-title 181
Alternative splicing: new insights from global analyses
###end article-title 181
###begin article-title 182
Systematic identification and analysis of exonic splicing silencers
###end article-title 182
###begin article-title 183
Comparative analysis identifies exonic splicing regulatory sequences--The complex definition of enhancers and silencers
###end article-title 183
###begin article-title 184
Atypical 5' splice sites cause CFTR exon 9 to be vulnerable to skipping
###end article-title 184
###begin article-title 185
Accurate identification of alternatively spliced exons using support vector machine
###end article-title 185
###begin article-title 186
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 6 11 <span type="species:ncbi:10090">mouse</span>
Human-mouse comparative analysis reveals that branch-site plasticity contributes to splicing regulation
###end article-title 186
###begin article-title 187
hnRNP complexes: composition, structure, and function
###end article-title 187
###begin article-title 188
Messenger-RNA-binding proteins and the messages they carry
###end article-title 188
###begin article-title 189
Intronic binding sites for hnRNP A/B and hnRNP F/H proteins stimulate pre-mRNA splicing
###end article-title 189
###begin article-title 190
Serine/arginine-rich protein-dependent suppression of exon skipping by exonic splicing enhancers
###end article-title 190
###begin article-title 191
###xml 82 87 <span type="species:ncbi:4932">yeast</span>
###xml 96 102 <span type="species:ncbi:9606">humans</span>
RS domains contact splicing signals and promote splicing by a common mechanism in yeast through humans
###end article-title 191
###begin article-title 192
###xml 42 47 <span type="species:ncbi:9606">human</span>
Molecular basis of RNA recognition by the human alternative splicing factor Fox-1
###end article-title 192
###begin article-title 193
Multiple cis elements regulate an alternative splicing event at 4.1R pre-mRNA during erythroid differentiation
###end article-title 193
###begin article-title 194
Regulation of alternative pre-mRNA splicing by a novel repeated hexanucleotide element
###end article-title 194
###begin article-title 195
Control of alternative pre-mRNA splicing by distributed pentameric repeats
###end article-title 195
###begin article-title 196
Tissue-dependent isoforms of mammalian Fox-1 homologs are associated with tissue-specific splicing activities
###end article-title 196
###begin article-title 197
Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice
###end article-title 197
###begin article-title 198
Androgens regulate the mammalian homologues of invertebrate sex determination genes tra-2 and fox-1
###end article-title 198
###begin article-title 199
###xml 31 36 <span type="species:ncbi:9606">human</span>
A negative coregulator for the human ER
###end article-title 199
###begin article-title 200
###xml 18 40 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal splicing regulators in mammals
###end article-title 200
###begin article-title 201
Nova regulates brain-specific splicing to shape the synapse
###end article-title 201
###begin article-title 202
Nova autoregulation reveals dual functions in neuronal splicing
###end article-title 202
###begin article-title 203
Mammalian CELF/Bruno-like RNA-binding proteins: molecular characteristics and biological functions
###end article-title 203
###begin article-title 204
The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing
###end article-title 204
###begin article-title 205
The role of ADAM 15 in glomerular mesangial cell migration
###end article-title 205
###begin article-title 206
ADAM15 overexpression in NIH3T3 cells enhances cell-cell interactions
###end article-title 206
###begin article-title 207
Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1
###end article-title 207
###begin article-title 208
Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases
###end article-title 208
###begin article-title 209
###xml 73 78 <span type="species:ncbi:9606">human</span>
Identification of preferred protein interactions by phage-display of the human Src homology-3 proteome
###end article-title 209
###begin article-title 210
American Type Culture Collection
###end article-title 210
###begin article-title 211
GeneDoc: Analysis and Visualization of Genetic Variation
###end article-title 211
###begin article-title 212
Genedoc
###end article-title 212
###begin article-title 213
NCBI Blast home
###end article-title 213
###begin article-title 214
RepeatMasker
###end article-title 214
###begin article-title 215
EMBOSS: the European Molecular Biology Open Software Suite
###end article-title 215
###begin article-title 216
CpGPlot
###end article-title 216
###begin article-title 217
Match
###end article-title 217
###begin article-title 218
TRANSFAC: an integrated system for gene expression regulation
###end article-title 218
###begin article-title 219
[Composite regulatory elements: classification and description in the COMPEL database]
###end article-title 219
###begin article-title 220
COMPEL: a database on composite regulatory elements providing combinatorial transcriptional regulation
###end article-title 220
###begin article-title 221
CompelPatternSearch 1.0
###end article-title 221
###begin article-title 222
Identification of conserved regulatory elements by comparative genome analysis
###end article-title 222
###begin article-title 223
VISTA : visualizing global DNA sequence alignments of arbitrary length
###end article-title 223
###begin article-title 224
MAVID multiple alignment server
###end article-title 224
###begin article-title 225
PipMaker--a web server for aligning two genomic DNA sequences
###end article-title 225
###begin article-title 226
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
###end article-title 226
###begin article-title 227
NCBI Blast2seq
###end article-title 227
###begin article-title 228
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 6 11 <span type="species:ncbi:10090">mouse</span>
Human-mouse alignments with BLASTZ
###end article-title 228
###begin article-title 229
ASD: a bioinformatics resource on alternative splicing
###end article-title 229
###begin article-title 230
Comparative analysis detects dependencies among the 5' splice-site positions
###end article-title 230
###begin article-title 231
Variation in sequence and organization of splicing regulatory elements in vertebrate genes
###end article-title 231
###begin article-title 232
ESEfinder: A web resource to identify exonic splicing enhancers
###end article-title 232
###begin article-title 233
###xml 33 38 <span type="species:ncbi:9606">human</span>
A polymorphic GT repeat from the human cardiac Na+Ca2+ exchanger intron 2 activates splicing
###end article-title 233
###begin article-title 234
RNA binding specificity of hnRNP A1: significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing
###end article-title 234
###begin article-title 235
Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization
###end article-title 235
###begin article-title 236
Characterization of the mRNA ligands bound by the RNA binding protein hnRNP A2 utilizing a novel in vivo technique
###end article-title 236
###begin article-title 237
AUF1 binding affinity to A+U-rich elements correlates with rapid mRNA degradation
###end article-title 237
###begin article-title 238
Isolation and characterization of a novel, low abundance hnRNP protein: A0
###end article-title 238
###begin article-title 239
The UUAG-specific RNA binding protein, heterogeneous nuclear ribonucleoprotein D0. Common modular structure and binding properties of the 2xRBD-Gly family
###end article-title 239
###begin article-title 240
###xml 82 87 <span type="species:ncbi:9606">human</span>
Nuclear proteins that bind the pre-mRNA 3' splice site sequence r(UUAG/G) and the human telomeric DNA sequence d(TTAGGG)n
###end article-title 240
###begin article-title 241
###xml 111 114 <span type="species:ncbi:10116">rat</span>
Binding of hnRNP H to an exonic splicing silencer is involved in the regulation of alternative splicing of the rat beta-tropomyosin gene
###end article-title 241
###begin article-title 242
Intronic CA-repeat and CA-rich elements: a new class of regulators of mammalian alternative splicing
###end article-title 242
###begin article-title 243
SRp30c is a repressor of 3' splice site utilization
###end article-title 243
###begin article-title 244
SRp54 (SFRS11), a regulator for tau exon 10 alternative splicing identified by an expression cloning strategy
###end article-title 244
###begin article-title 245
The splicing regulatory element, UGCAUG, is phylogenetically and spatially conserved in introns that flank tissue-specific alternative exons
###end article-title 245
###begin article-title 246
The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo
###end article-title 246
###begin article-title 247
The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing
###end article-title 247
###begin article-title 248
Identification of putative new splicing targets for ETR-3 using sequences identified by systematic evolution of ligands by exponential enrichment
###end article-title 248
###begin article-title 249
Muscleblind proteins regulate alternative splicing
###end article-title 249
###begin article-title 250
Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats
###end article-title 250
###begin article-title 251
Wise2
###end article-title 251

